Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes
Marco Di Nicola, Maria Pepe, Silvia Montanari, Maria Chiara Spera, Isabella Panaccione, Alessio Simonetti, Gabriele Sani
Topics & Concepts
VortioxetineDigit symbol substitution testAnxietyMoodAnhedoniaTolerabilityCognitionDepression (economics)MedicineEffects of sleep deprivation on cognitive performanceMajor depressive episodePsychiatryPsychologyClinical psychologyInternal medicineMajor depressive disorderAdverse effectSchizophrenia (object-oriented programming)MacroeconomicsAlternative medicinePlaceboPathologyEconomicsTryptophan and brain disordersLong-Term Effects of COVID-19Intensive Care Unit Cognitive Disorders